APP and Alzheimer disease: There is a growing consensus that the failure to develop an effective intervention for AD may be due, in part, to the fact that almost all past preclinical and clinical trials have been designed to target individual pathological features, which in the past two decades, mainly focus on various forms of Aβ and APP processing.